Flanimus
Breathalyzer Test for Diagnosing Coronavirus
StartupFlanimus is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2020. Breathalyzer Test for Diagnosing Coronavirus. Flanimus was founded by Gabby Sarusi. The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials, Semiconductors & Electronics, Platforms & Interfaces, Software.
The company follows a B2B business model. Product stage: Clinical Trial.
- StagePre-Funding
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
Gabby SarusiFounder
What does Flanimus do?
Flanimus is a simple, one-minute breathalyzer test for diagnosing the coronavirus at the cost of three dollars per test. The Flanimus test can be performed at any location and by any operator, without the need for trained staff or dedicated labs. The device comprises two main parts: a disposable capsule with a chip inside and a spectrometer. After breathing into the capsule, it is inserted into the spectrometer, and the spectral signature of the virus is detected using proprietary software.
Who founded Flanimus?
Flanimus was founded in 2020 by Gabby Sarusi (Founder).
What sector is Flanimus in?
Flanimus operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Materials & Substances, Nanomaterials, Semiconductors & Electronics, Platforms & Interfaces, Software. Target customers: Travel & Tourism.
Where is Flanimus located?
Flanimus is based in Rehovot, Israel, Center District.